Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Verastem Q2 Adj $(0.61) Beats $(0.95) Estimate, Sales $10.00K Miss $50.00K Estimate

Author: Benzinga Newsdesk | August 08, 2024 05:18pm
Verastem (NASDAQ:VSTM) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(0.95) by 35.79 percent. This is a 42.45 percent increase over losses of $(1.06) per share from the same period last year. The company reported quarterly sales of $10.00 thousand which missed the analyst consensus estimate of $50.00 thousand by 80.00 percent.

Posted In: VSTM

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist